Clinical observation of Wumei Tougu decoction combined with methotrexate in treating rheumatoid arthritis

Tiantian YANG,Zhenyu WANG
DOI: https://doi.org/10.3969/j.issn.1008-8849.2018.07.009
2018-01-01
Abstract:Objective It is to observe the clinical efficacy of Wumei Tougu decoction combined with methotrexate in the treatment of rheumatoid arthritis (RA) with syndrome of liver-kidney deficiency and stasis.Methods Sixty cases of patients with rheumatoid arthritis with syndrome of liver-kidney deficiency and stasis were divided into treatment group and control group according to the different medication regimen,each group had 30 cases.The treatment group was treated with Wumei Tougu decoction combined with methotrexate and slow-released votalin tablet,the control group was treated with methotrexate and slow-released votalin tablet.The two groups were treated for 12 weeks.The changes of main symptoms and signs (joint tenderness,joint pain,joint swelling,morning stiffness,joint swelling remission,etc.) were observed,and laboratory parameters such as rheumatoid factor (RF),C-reactive protein (CRP),erythrocyte sedimentation rate (ESR) were measured in both groups.Results The total effective rate in the treatment group was 86.7%,which was significantly higher than that 73.3% in the control group (P < 0.05).After treatment,the indexes of joint tenderness,joint swelling,morning stiffness (min),pain degree,RF,CRP and ESR were significantly improved in both groups (P < 0.05),but the improvements in the treatment group was significantly better than those in the control group (P < 0.05).Conclusion Wumei Tougu decoction combined with methotrexate has a significant curative effect on rheumatoid arthritis with syndrome of liver-kidney deficiency and stasis.
What problem does this paper attempt to address?